Your browser doesn't support javascript.
loading
Immunogenicity induced by two and three doses of the BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic diseases and immunocompetent controls: a longitudinal multicentre study.
Furer, Victoria; Eviatar, Tali; Freund, Tal; Peleg, Hagit; Paran, Daphna; Levartovsky, David; Kaufman, Ilana; Broyde, Adi; Elalouf, Ofir; Polachek, Ari; Feld, Joy; Haddad, Amir; Gazitt, Tal; Elias, Muna; Higazi, Nizar; Kharouf, Fadi; Gertel, Smadar; Pel, Sara; Nevo, Sharon; Hagin, David; Zisman, Devy; Elkayam, Ori.
Afiliação
  • Furer V; Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel furer.rheum@gmail.com.
  • Eviatar T; Tel Aviv University Sackler Faculty of Medicine, Tel Aviv, Israel.
  • Freund T; Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Peleg H; Tel Aviv University Sackler Faculty of Medicine, Tel Aviv, Israel.
  • Paran D; Tel Aviv University Sackler Faculty of Medicine, Tel Aviv, Israel.
  • Levartovsky D; Allergy and Clinical Immunology Unit, Department of Medicine, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Kaufman I; Rheumatology, Hadassah University Medical Center, Jerusalem, Israel.
  • Broyde A; Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Elalouf O; Tel Aviv University Sackler Faculty of Medicine, Tel Aviv, Israel.
  • Polachek A; Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Feld J; Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Haddad A; Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Gazitt T; Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Elias M; Tel Aviv University Sackler Faculty of Medicine, Tel Aviv, Israel.
  • Higazi N; Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Kharouf F; Tel Aviv University Sackler Faculty of Medicine, Tel Aviv, Israel.
  • Gertel S; Carmel Medical Center, Haifa, Israel.
  • Pel S; Medicine, Technion Israel Institute of Technology, Haifa, Israel.
  • Nevo S; Carmel Medical Center, Haifa, Israel.
  • Hagin D; Medicine, Technion Israel Institute of Technology, Haifa, Israel.
  • Zisman D; Carmel Medical Center, Haifa, Israel.
  • Elkayam O; Medicine, Technion Israel Institute of Technology, Haifa, Israel.
Ann Rheum Dis ; 81(11): 1594-1602, 2022 11.
Article em En | MEDLINE | ID: mdl-35868846
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Doenças Reumáticas / Imunogenicidade da Vacina / COVID-19 / Vacina BNT162 Tipo de estudo: Clinical_trials / Observational_studies Limite: Adult / Humans Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Israel
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Doenças Reumáticas / Imunogenicidade da Vacina / COVID-19 / Vacina BNT162 Tipo de estudo: Clinical_trials / Observational_studies Limite: Adult / Humans Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Israel